Extracellular	B-Cellular_component
matrix	I-Cellular_component
as	O
a	O
bioactive	O
material	O
for	O
soft	B-Tissue
tissue	I-Tissue
reconstruction	O
.	O

The	O
extracellular	B-Cellular_component
matrix	I-Cellular_component
(	O
ECM	B-Cellular_component
)	O
directs	O
all	O
phases	O
of	O
healing	O
following	O
trauma	O
or	O
disease	O
and	O
is	O
therefore	O
a	O
natural	O
source	O
of	O
prosthetic	O
mesh	O
material	O
that	O
can	O
be	O
used	O
strategically	O
to	O
induce	O
the	O
repair	O
and	O
restoration	O
of	O
soft	B-Tissue
tissues	I-Tissue
following	O
surgery	O
.	O

Biomaterials	O
such	O
as	O
Surgisis	O
(	O
Cook	O
Biotech	O
Incorporated	O
,	O
West	O
Lafayette	O
,	O
IN	O
,	O
USA	O
)	O
,	O
which	O
are	O
derived	O
from	O
natural	O
ECM	B-Cellular_component
,	O
provide	O
the	O
extracellular	B-Cellular_component
components	I-Cellular_component
necessary	O
to	O
direct	O
the	O
healing	O
response	O
,	O
allow	O
for	O
the	O
proliferation	O
of	O
new	O
,	O
healthy	O
tissue	B-Tissue
and	O
restore	O
tissue	B-Tissue
integrity	O
to	O
the	O
damaged	O
site	B-Tissue
.	O

The	O
3	O
-	O
D	O
organization	O
of	O
these	O
extracellular	B-Cellular_component
components	I-Cellular_component
distinguishes	O
the	O
Surgisis	O
mesh	O
from	O
synthetic	O
materials	O
and	O
is	O
associated	O
with	O
constructive	O
tissue	B-Tissue
remodelling	O
instead	O
of	O
scar	B-Tissue
tissue	I-Tissue
.	O

Common	O
features	O
of	O
this	O
ECM	B-Cellular_component
-	O
assisted	O
tissue	B-Tissue
remodelling	O
include	O
angiogenesis	O
,	O
recruitment	O
of	O
circulating	O
progenitor	B-Cell
cells	I-Cell
and	O
constructive	O
remodelling	O
of	O
damaged	O
tissue	B-Tissue
structures	O
.	O

The	O
tissue	B-Tissue
response	O
to	O
this	O
biologic	O
mesh	O
is	O
discussed	O
in	O
the	O
context	O
of	O
recent	O
reports	O
on	O
clinical	O
hernia	B-Pathological_formation
repair	O
.	O

